A novel loss of function mutation in exon 10 of the FSH receptor gene causing hypergonadotrophic hypogonadism: clinical and molecular characteristics.

BACKGROUND Inactivating mutations of the FSH receptor (FSHR) are a rare cause of hypergonadotrophic hypogonadism in women. Only one patient with primary amenorrhoea due to an FSHR gene mutation has been reported outside of Finland, where the prevalence of Ala189Val mutations is particularly high. METHODS AND RESULTS Here, we describe the clinical, molecular genetic and functional characteristics associated with a novel inactivating mutation in exon 10 of the FSHR gene identified in a patient who presented with primary amenorrhoea at 17 years of age. The C to G transversion found at nucleotide 1043 causes a Pro348Arg substitution in the extracellular region of the FSHR and results in a mutant FSHR that is completely inactive in functional studies and that does not bind FSH. The proband exhibits apparent homozygosity for this recessive mutation. Her father is heterozygous for the mutation while analysis of exon 10 of the FSHR gene from her mother revealed only wild-type sequence. Chromosome painting was used to exclude deletions or rearrangements of 2p, and microsatellite markers did not show paternal uniparental isodisomy for this region. These findings suggest that the proband is hemizygous, with an inherited or de-novo microdeletion, or alternatively a de-novo gene conversion, of the accompanying FSHR allele. CONCLUSIONS This case confirms the importance of the FSHR in female pubertal development and reproduction, and supports a relationship between phenotype and function for FSHR mutations.

[1]  K. Aittomäki,et al.  Functional characterization of the human FSH receptor with an inactivating Ala189Val mutation. , 2002, Molecular human reproduction.

[2]  K. Aittomäki,et al.  A Novel mutation in the FSH receptor inhibiting signal transduction and causing primary ovarian failure. , 2002, The Journal of clinical endocrinology and metabolism.

[3]  I. Huhtaniemi,et al.  Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function. , 2000, Endocrine reviews.

[4]  I. Huhtaniemi,et al.  The effect of a null mutation in the follicle-stimulating hormone receptor gene on mouse reproduction. , 2000, Endocrinology.

[5]  E. Milgrom,et al.  New natural inactivating mutations of the follicle-stimulating hormone receptor: correlations between receptor function and phenotype. , 1999, Molecular endocrinology.

[6]  G. Conway,et al.  Mutation screening and isoform prevalence of the follicle stimulating hormone receptor gene in women with premature ovarian failure, resistant ovary syndrome and polycystic ovary syndrome , 1999, Clinical endocrinology.

[7]  J. Baron,et al.  Hypogonadotropic hypogonadism in a female caused by an X-linked recessive mutation in the DAX1 gene. , 1999, The New England journal of medicine.

[8]  S. Toledo.  Inactivating mutations of the LH receptor gene: more than two different phenotypes. , 1999, European journal of endocrinology.

[9]  D. Kotzot.  Abnormal phenotypes in uniparental disomy (UPD): fundamental aspects and a critical review with bibliography of UPD other than 15. , 1999, American journal of medical genetics.

[10]  A. de la Chapelle,et al.  The frequency of an inactivating point mutation (566C-->T) of the human follicle-stimulating hormone receptor gene in four populations using allele-specific hybridization and time-resolved fluorometry. , 1998, The Journal of clinical endocrinology and metabolism.

[11]  A. Gansmuller,et al.  Impairing follicle-stimulating hormone (FSH) signaling in vivo: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[12]  E. Milgrom,et al.  A novel phenotype related to partial loss of function mutations of the follicle stimulating hormone receptor. , 1998, The Journal of clinical investigation.

[13]  L. Layman,et al.  The Finnish follicle-stimulating hormone receptor gene mutation is rare in North American women with 46,XX ovarian failure. , 1998, Fertility and sterility.

[14]  E. Nieschlag,et al.  The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. , 1997, Endocrine reviews.

[15]  J. Uitto,et al.  Revertant Mosaicism in Epidermolysis Bullosa Caused by Mitotic Gene Conversion , 1997, Cell.

[16]  K. Aittomäki,et al.  Men homozygous for an inactivating mutation of the follicle-stimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility , 1997, Nature Genetics.

[17]  E. Nieschlag,et al.  Functional and clinical consequences of mutations in the FSH receptor , 1996, Molecular and Cellular Endocrinology.

[18]  A. de la Chapelle,et al.  Clinical features of primary ovarian failure caused by a point mutation in the follicle-stimulating hormone receptor gene. , 1996, The Journal of clinical endocrinology and metabolism.

[19]  C. Bourdony,et al.  Compound heterozygous mutations of the luteinizing hormone receptor gene in Leydig cell hypoplasia. , 1996, Molecular endocrinology.

[20]  A. Chapelle,et al.  Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure , 1995, Cell.

[21]  S. Karonen,et al.  An enzymatic solid-phase method for trace iodination of proteins and peptides with 125-iodine. , 1975, Analytical biochemistry.

[22]  B. Haddad,et al.  Segmental uniparental isodisomy without clinical symptoms: implications for UPD and other genetic studies of chromosome 2 , 2001 .

[23]  Peter Beighton,et al.  de la Chapelle, A. , 1997 .